GMP-certified biomanufacturing
Medicine security, engineered end to end.
Adjuvant Bio develops, manufactures, and distributes generic and biosimilar therapeutics at national scale, from bulk drug substance to the pharmacy shelf.
0
Products in market
0
Units per year
0
Markets served
The Mandate
A sovereign supply of essential medicine.
When a supply chain is national infrastructure, it cannot depend on someone else's factory. Adjuvant Bio owns the whole chain: molecule to vial to distribution, under one quality system.
Read the mandate →Portfolio
0
Products in market
Output
0
Units per year
Footprint
0
GMP facilities
Reach
0
Markets served
Infrastructure
Four sites, one quality system.
Bulk Drug Substance Plant
Calder Vale, Northmoor
Mammalian cell culture, up to 6 × 2,000 L single-use bioreactors.
12,000 L installedGrade C/D cleanroomsContinuous perfusion ready
Sterile Fill-Finish
Calder Vale, Northmoor
Vial and pre-filled syringe lines under isolator technology.
120M units/yrGrade A isolators100% automated inspection
Quality Control Campus
Ashcombe, Northmoor
Release and stability testing, method development, microbiology.
Mass spec suiteGMP micro lab24/7 stability chambers
Distribution & Cold Chain
Wrenport, Eastreach
2-8 °C and -20 °C national distribution with live telemetry.
40,000 pallet positionsGDP certifiedIoT-monitored
Contact
Talk to the supply team.
Procurement, partnership, or press. Reach the right desk.